Cargando…
MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) comprises about 84% of all lung cancers. Many treatment options are available but the survival rate is still very low due to drug resistance. It has been found that phosphoinositide-3-kinase (PI3K) affects sensitivity to tyrosine kinase inhibitors (TKIs), including...
Autores principales: | Chan, Lawrence W. C., Wang, Fengfeng, Meng, Fei, Wang, Lili, Wong, Sze Chuen Cesar, Au, Joseph S. K., Yang, Sijun, Cho, William C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288379/ https://www.ncbi.nlm.nih.gov/pubmed/28210267 http://dx.doi.org/10.3389/fgene.2017.00008 |
Ejemplares similares
-
Combination therapy of gefitinib and miR-30a-5p may overcome acquired
drug resistance through regulating the PI3K/AKT pathway in non-small cell lung
cancer
por: Wang, Fengfeng, et al.
Publicado: (2020) -
MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
por: Meng, Fei, et al.
Publicado: (2016) -
Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer
por: Wang, Fengfeng, et al.
Publicado: (2016) -
Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma
por: Wang, Menglan, et al.
Publicado: (2021) -
Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia
por: Wang, Fengfeng, et al.
Publicado: (2016)